CCA
BSX icon

Criterion Capital Advisors’s Boston Scientific BSX Stock Holding History

Criterion Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$117K Hold
1,515
– – 0.07% 88
2024
Q3 		$117K Hold
1,515
– – 0.07% 88
2024
Q2 		$117K Hold
1,515
– – 0.07% 88
2024
Q1 		$104K Hold
1,515
– – 0.07% 95
2023
Q4 		$87.6K Buy
+1,515
New +$80.9K 0.06% 98

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Criterion Capital Advisors's BSX Position: Q4 2024 in Review

Criterion Capital Advisors held its Boston Scientific (BSX) position steady in Q4 2024 at 1,515 shares worth $117K. The position accounts for 0.07% of the portfolio, ranked #88.

Criterion Capital Advisors first reported a position in BSX in Q4 2023 and has held it in 5 quarters since. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Criterion Capital Advisors held 1,515 shares of Boston Scientific worth $117K as of Q4 2024.
  • Criterion Capital Advisors left its Boston Scientific share count unchanged in Q4 2024.
  • Boston Scientific made up 0.07% of Criterion Capital Advisors's portfolio in Q4 2024, its #88 holding.
  • Criterion Capital Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 5 quarters since.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.